Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04079556 · ClinicalTrials.gov registry record · NA

Reducing Breast Cancer Risk in Korean American Women

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT04079556 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04079556, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

The goals of the study are to develop a culturally and linguistically appropriate intervention to reduce SHS exposure for LEP Korean women using a family-focused intervention approach targeting Korean Americans ages 18 and above in the greater San Francisco Bay Area, CA, and to evaluate efficacy of the proposed intervention. The study is a single group feasibility trial targeting a total of 4 lay health workers (LHW) and 24 dyads of LEP Korean women with self-reported SHS exposure at home and a male household smoker. The hypothesis is: H. Can a family-based intervention approach reduce SHS exposure among Korean American women who live with a current smoker?

Interventions

  • BEHAVIORAL Tobacco LHW

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2019-03-16
Est. Completion 2019-12-31
Phase NA

What the Registry Record Tells You About NCT04079556

The ClinicalTrials.gov registry entry for NCT04079556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Tobacco LHW is the first listed.

NCT04079556 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04079556 about?

NCT04079556 is a clinical study titled "Reducing Breast Cancer Risk in Korean American Women". The goals of the study are to develop a culturally and linguistically appropriate intervention to reduce SHS exposure for LEP Korean women using a family-focused intervention approach targeting Korean Americans ages 18 and above in the greater San Francisco Bay Area, CA, and to evaluate efficacy of ...

What is the current status of trial NCT04079556?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2019-03-16. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT04079556?

The interventions under investigation include: Tobacco LHW (BEHAVIORAL).

Who is sponsoring clinical trial NCT04079556?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.